<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Thompson Emerson | Activity</title>
	<link>https://www.catswannabecats.com/members/wordhook6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/wordhook6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Thompson Emerson.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">c405934ebfd60f4144959869fb7ec668</guid>
				<title>Thompson Emerson posted an update: Additionally, pretreatment of sporozoites with [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23639/</link>
				<pubDate>Sun, 08 Jun 2025 09:58:47 -0400</pubDate>

									<content:encoded><![CDATA[<p>Additionally, pretreatment of sporozoites with rEtAMA3-specific antibodies substantially impeded their invasion into host cells. These results suggest EtAMA3 is a sporozoite-specific protein that is involved in host-cell sporozoite invasion.The past decades have witnessed hyperthermia therapy (HTT) as an emerging strategy against malignant tumors.&hellip;<span class="activity-read-more" id="activity-read-more-23639"><a href="https://www.catswannabecats.com/activity/p/23639/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6926ae6b84b0afc0a4959b5fa0e8605c</guid>
				<title>Thompson Emerson posted an update: When the ceramide ratio is low, the thickness of lipid [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18669/</link>
				<pubDate>Wed, 04 Jun 2025 10:14:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>When the ceramide ratio is low, the thickness of lipid bilayer is reduced and its structure is weakened. Other structural differences between the lipid layers of normal and atopic skin included increased area per lipid and poor alignment of lipids. Further, the atopy lipid bilayer model was found to absorb more SLES than the normal skin lipid&hellip;<span class="activity-read-more" id="activity-read-more-18669"><a href="https://www.catswannabecats.com/activity/p/18669/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ab1c06b567fc63f7855bd6ab9f000aac</guid>
				<title>Thompson Emerson posted an update: The current study examines depression and pain as potential [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4720/</link>
				<pubDate>Sat, 31 May 2025 13:49:22 -0400</pubDate>

									<content:encoded><![CDATA[<p>The current study examines depression and pain as potential contributors to patient-provider discordance in the assessment of lupus disease activity. The study conducted a secondary analysis of data obtained from the Childhood Arthritis and Rheumatology Research Alliance registry, with N = 859 adolescent participants. Assessments of pain, dis&hellip;<span class="activity-read-more" id="activity-read-more-4720"><a href="https://www.catswannabecats.com/activity/p/4720/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b1fcbd5e48601742754fe545d34faa8c</guid>
				<title>Thompson Emerson became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4662/</link>
				<pubDate>Sat, 31 May 2025 13:37:25 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>